Medulloblastoma News and Research

RSS
Researchers identify cells that likely give rise to Group 4 medulloblastoma

Researchers identify cells that likely give rise to Group 4 medulloblastoma

Scientists discover protein interaction that describes aggressive subtype of medulloblastoma

Scientists discover protein interaction that describes aggressive subtype of medulloblastoma

UNC researchers uncover new potential strategy to kill cancerous cells in the brain

UNC researchers uncover new potential strategy to kill cancerous cells in the brain

Sohn Conference Foundation awards $50,000 grant to support cutting-edge pediatric clinical trial in New York

Sohn Conference Foundation awards $50,000 grant to support cutting-edge pediatric clinical trial in New York

ICGC article lays foundation for the coming era of cancer genomic research

ICGC article lays foundation for the coming era of cancer genomic research

Roflumilast drug could inhibit growth of brain tumor in children

Roflumilast drug could inhibit growth of brain tumor in children

Ion channel blockers prove useful in cancer therapy

Ion channel blockers prove useful in cancer therapy

Vismodegib therapy effective against medulloblastoma

Vismodegib therapy effective against medulloblastoma

UofL conducts Phase I research study for children with relapsed tumors

UofL conducts Phase I research study for children with relapsed tumors

Four young scientists named recipients of Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award

Four young scientists named recipients of Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award

Researchers complete phase 1 clinical trial of new drug for children suffering from neuroblastoma

Researchers complete phase 1 clinical trial of new drug for children suffering from neuroblastoma

Dell extends partnership with TGen to globally expand precision medicine trial for pediatric cancer

Dell extends partnership with TGen to globally expand precision medicine trial for pediatric cancer

Fennec presents positive interim results from phase III trial of sodium thiosulphate at ASCO 2015

Fennec presents positive interim results from phase III trial of sodium thiosulphate at ASCO 2015

New nationwide survey shows steady increase in pediatric patients treated with proton radiation therapy

New nationwide survey shows steady increase in pediatric patients treated with proton radiation therapy

Study sheds light on developing more targeted therapies against medulloblastoma

Study sheds light on developing more targeted therapies against medulloblastoma

Quantitative phosphoproteomic approach to identify targeted cancer therapy

Quantitative phosphoproteomic approach to identify targeted cancer therapy

Novogen's TRXE-009 therapy shows promise against brain cancer

Novogen's TRXE-009 therapy shows promise against brain cancer

MD Anderson awarded more than $22 million in research grants from CPRIT

MD Anderson awarded more than $22 million in research grants from CPRIT

New study links cell communication pathway to common brain tumors found in children

New study links cell communication pathway to common brain tumors found in children

Pre-clinical studies confirm TRXE-009 as new potential treatment for melanoma

Pre-clinical studies confirm TRXE-009 as new potential treatment for melanoma